Analyse de l'application eMIMSelite pour le 9 octobre

MIMS Australia introduces eMIMSelite, a premium medicine reference subscription designed to support healthcare professionals in delivering high-quality patient care, even in offline environments. eMIMSelite offers extensive, validated information on all registered medicines in Australia, along with specialised content including drug-disease contraindications, safe administration of IV injectables, sports medicine, and dental monographs. Key features include: Offline access ensuring uninterrupted use regardless of internet connectivity. Advanced authentication and integration with organizational libraries. Rapid search and retrieval of product information, consumer medicine information, product images, drug interactions, and PBS data. MIMS Interaction Checker to identify: a. Potentially harmful combinations of medicines b. Medicines that may be unsuitable due to the patient’s allergy profile c. Medicines that may be unsuitable due to a health condition Easy access to need-to-know information on medicine and solution compatibility for safe administration of IV injectable medicines. Access essential dental-specific medicine information such as effects on dental treatment, recommendations for dental patients, and more. Identify potentially prohibited medications in and out of competition based on the World Anti Doping Agency (WADA) list. Premium Tool, Specialized Curated Content Disclaimer: eMIMSelite is strictly meant to be used by Healthcare Professionals – Doctors, Nurses, Pharmacists & Medical Students. For more information: https://emims.plus/emimselite/ To access the platform: https://app.emims.plus/signup For Support: Email: subscriptions@mims.com.au Phone: 1800 800 629 Available: Monday – Friday, 9:00 AM – 5:00 PM AEST